ME AGAIN A STORY OF DAO DEFICIENCY Trademark
Serial Number: 79345982
ME AGAIN A STORY OF DAO DEFICIENCY is a trademark filed by
DR. HEALTHCARE ESPAÑA, S.L.
on May 23, 2022. The trademark is classified under Class 5 (Pharmaceuticals).
The application is currently no longer active.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
MARCH & ASOCIADOS
Passeig de Gràcia, 103, 7ª Planta
E-08008 Barcelona,
SPAIN
Trademark Details
Filing Date
May 23, 2022
Registration Date
Not Registered
Goods & Services
Pharmaceutical products, namely, pharmaceutical products for dietary purposes in the form of slimming pills, capsules, preparations in powder form to promote fat burning; nutritional supplements; dietetic preparations adapted for medical use; vitamin preparations; mineral food supplements; dietetic foods and food supplements adapted for medical purposes
Filing History
NEW REPRESENTATIVE AT IB RECEIVED
Apr 2, 2026 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 24, 2024 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Aug 5, 2024 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 5, 2024 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jan 21, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 3, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jan 3, 2024 OPNR
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Aug 7, 2023 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Aug 4, 2023 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Aug 4, 2023 ABN2
REFUSAL PROCESSED BY IB
Feb 14, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 20, 2023 RFCS
REFUSAL PROCESSED BY MPU
Jan 20, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 15, 2022 RFCR
NON-FINAL ACTION WRITTEN
Nov 14, 2022 CNRT
ASSIGNED TO EXAMINER
Nov 11, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 2, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 29, 2022 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jul 28, 2022 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 28, 2022 REPR
